Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;21(10):3436-3443.
doi: 10.1111/ajt.16714. Epub 2021 Jul 10.

Febrile neutropenia after kidney transplantation

Geoffrey K Dube  1 , Heather K Morris  1 , Russell J Crew  1 , Marcus R Pereira  2 , David J Cohen  1 , Sumit Mohan  1   3   4 , Syed A Husain  1   3
Affiliations
Free article

Febrile neutropenia after kidney transplantation

Geoffrey K Dube et al. Am J Transplant. 2021 Oct.
Free article

Abstract

Neutropenia is common after kidney transplant. There are few data on febrile neutropenia episodes (FNE) after kidney transplant. We studied FNE in a single-center retrospective cohort of 1682 kidney transplant recipients. Neutropenia (absolute neutrophil count [ANC] <1000) occurred in 32% and FNE in 3%. There were 56 FNE. Median time to FNE was 143 days, and median time from onset of neutropenia to onset of FNE was 5.5 days. The most common sources of infection were urine, blood, and lungs, and in 20% of FNE no source was identified. No infectious organism was identified in 46% of FNE, and opportunistic infections were uncommon. Patient survival was similar among those with and without FNE, but FNE was associated with increased death-censored graft failure (DCGF). Following FNE, acute rejection occurred in 31% and DCGF in 15%, often in the setting of persistent reduced immunosuppression. In conclusion, FNE are common after kidney transplant and are associated with inferior long-term outcomes.

Keywords: clinical research / practice; complication: infectious; infection and infectious agents - bacterial; infectious disease; kidney transplantation / nephrology; side effects; transitional care.

PubMed Disclaimer

References

REFERENCES

    1. Hartmann EL, Gatesman M, Roskopf-Somerville J, Stratta R, Farney A, Sundberg A. Management of leukopenia in kidney and pancreas transplant recipients. Clin Transplant. 2008;22(6):822-828.
    1. Hurst FP, Belur P, Nee R, et al. Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States renal data system. Transplantation. 2011;92(1):36-40.
    1. Mavrakanas TA, Fournier M-A, Clairoux S, et al. Neutropenia in kidney and liver transplant recipients: risk factors and outcomes. Clin Transplant. 2017;31(10):e13058.
    1. Zafrani L, Truffaut L, Kreis H, et al. Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant. 2009;9(8):1816-1825.
    1. Reindl-Schwaighofer R, Oberbauer R. Blood disorders after kidney transplantation. Transplant Rev (Orlando). 2014;28(2):63-75.

MeSH terms